Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Diabetes Technology & Therapeutics|February 16, 2026
Accuracy of Real-Time Continuous Glucose Monitoring System in Hospitalized Patients with Diabetes and Chronic Kidney DiseaseYoshinori Kakutani, Tomoaki Morioka, Shoko Miyamoto, et al.Internal Medicine (Tokyo, Japan)|February 9, 2022
New-onset Type 1 Diabetes after COVID-19 mRNA VaccinationMasahiro Yano, Tomoaki Morioka, Yuka Natsuki, et al.Journal of Diabetes Investigation|February 15, 2022
New-onset fulminant type 1 diabetes after severe acute respiratory syndrome coronavirus 2 vaccination: A case reportKeyaki Sasaki, Tomoaki Morioka, Natsumi Okada, et al.Journal of Atherosclerosis and Thrombosis|May 24, 2023
Serum Fibroblast Growth Factor 23 Levels are Associated with Vascular Smooth Muscle Dysfunction in Type 2 DiabetesYuka Natsuki, Tomoaki Morioka, Yoshinori Kakutani, et al.Internal Medicine (Tokyo, Japan)|May 8, 2022
Seronegative Full-house Nephropathy with Crohn's DiseaseHideki Uedono, Akihiro Tsuda, Noriko Ueno, et al.Endocrine Journal|September 9, 2021
Role of adiponectin in the relationship between visceral adiposity and fibroblast growth factor 23 in non-diabetic men with normal kidney functionYuka Natsuki, Tomoaki Morioka, Shinya Fukumoto, et al.Endocrine Journal|August 28, 2024
A case of central diabetes insipidus after COVID-19 as a probable diagnosis of lymphocytic infundibulo-neurohypophysitis with positive anti-rabphilin-3A antibodies with review of literatureYuka Natsuki, Yuki Nagata, Toshiki Nagasaki, et al.Pageof 1